Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
This article was originally published in The Tan Sheet
FDA issued public notifications against 20 products marketed as weight-loss supplements containing the withdrawn Rx ingredient sibutramine.
You may also be interested in...
FDA’s plan to tighten enforcement of new dietary ingredient notifications with its controversial guidance still in draft form raises concerns for some stakeholders.
A week after FDA warned manufacturers about tighter enforcement against tainted dietary supplements, a MedWatch notice identifies an adulterated weight-loss product that appears to fit the agency's criteria for warranting regulatory action.
FDA's consumer advisory against a coffee product that contains an active drug ingredient for erectile dysfunction reflects the agency's growing capability to keep up with noncompliant firms that add drug substances to so-called dietary supplements